Drug intelligence / Profile preview

koeleria macrantha pollen

Development stage
Unknown
Lead developer
Greer Laboratories
Administration
Subcutaneous, Intradermal, Sublingual, Intranasal
01

Overview

Koeleria macrantha pollen is an allergenic extract derived from the pollen of the prairie Junegrass (*Koeleria macrantha*), a species native to Eurasia and North America. It is classified as a biologic product and is primarily used for the diagnosis and treatment of IgE-mediated allergic conditions such as allergic rhinitis (hay fever) and allergic asthma. For diagnostic purposes, it is used in skin prick or intradermal testing to identify sensitivity to grass pollens. For therapeutic purposes, it is used in allergen immunotherapy (AIT), where patients are administered gradually increasing doses of the extract to induce clinical and immunological tolerance. This process involves shifting the immune response from a Th2-mediated allergic profile to a Th1 and regulatory T-cell (Treg) response, reducing the production of allergen-specific IgE and increasing protective IgG4 antibodies. The product has been licensed in the United States since the late 1960s.

Other names
prairie Junegrass pollencrested hair-grass pollenJunegrass pollenKoeleria macrantha pollen extract
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on koeleria macrantha pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on koeleria macrantha pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call